The trajectory of Viagra, formerly marketed by copyright, presents a fascinating case study for backers considering the pharmaceutical landscape . While its initial success and generation of countless in earnings , the patent lapse has opened the door for alternative medications, substantially reducing income opportunities. This transition raises r